Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Compton John G. — 20/20 Biolabs, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Compton John G.

Compton John G.

Director at 20/20 Biolabs, Inc. · on record since Feb 23, 2026

Insider trading activity of Compton John G.

Transactions on record: 2; since Feb 23, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 23, 2026

Figures computed from official regulatory filings — methodology.

Companies where Compton John G. has traded

20/20 Biolabs, Inc.2 tx · Feb 23, 2026

Track record of Compton John G.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Compton John G.

Co-insiders of Compton John G.

Baker Ron20/20 Biolabs, Inc.
Bergman Alan B.20/20 Biolabs, Inc.
Cohen Jonathan M20/20 Biolabs, Inc.
COHEN RICHARD M20/20 Biolabs, Inc.
Lebowitz Michael Saul20/20 Biolabs, Inc.
Reddy Prasanth20/20 Biolabs, Inc.
Rollins John Woodson20/20 Biolabs, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Ross Michael A.20/20 Biolabs, Inc.

Zhou Jiming20/20 Biolabs, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
20/20 Biolabs, Inc.	Feb 23, 2026	OtherD	-7,669	—	—	SEC
20/20 Biolabs, Inc.	Feb 23, 2026	Other	7,669	0.00 USD	$0	SEC